Amylyx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, for the treatment of ALS. It is also developing AMX0035 for other neurodegenerative diseases. The company was founded in 2013 and is headquartered in Cambridge, MA.
What is Amylyx Pharmaceuticals's quote symbol?
What is the 52 week high and low for Amylyx Pharmaceuticals (NASDAQ: AMLX)?
How much is Amylyx Pharmaceuticals stock worth today?
How much is Amylyx Pharmaceuticals's stock price per share?
What is Amylyx Pharmaceuticals's Market Cap?